Literature DB >> 27469383

Expanding the range of immunopathology in neuromyelitis optica spectrum disorder.

Jennifer Massey1, Michael E Buckland2, Yael Barnett1, Ian Sutton1.   

Abstract

Neuromyelitis optica (NMO) spectrum disorder typically associates with a pathognomonic antibody response directed against aquaporin 4 and a unique immunopathological signature characterised by loss of aquaporin 4 expression. We describe a tumefactive presentation of NMO in which a biopsy specimen demonstrated active demyelination and reactive astrocytes with preserved surface aquaporin 4 immunoreactivity and dystrophic processes. While the astrocytic pathology is more typical of classical multiple sclerosis, a positive NMO-IgG (1:80) and subsequent clinical presentation with an area postrema syndrome is consistent with a diagnosis of NMO spectrum disorder. This report expands the immunopathological features that have been reported in NMO spectrum disorder. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27469383      PMCID: PMC4986154          DOI: 10.1136/bcr-2016-215981

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.

Authors:  Kensuke Ikeda; Naoki Kiyota; Hiroshi Kuroda; Douglas Kazutoshi Sato; Shuhei Nishiyama; Toshiyuki Takahashi; Tatsuro Misu; Ichiro Nakashima; Kazuo Fujihara; Masashi Aoki
Journal:  Mult Scler       Date:  2014-09-25       Impact factor: 6.312

2.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

3.  Brain abnormalities in neuromyelitis optica.

Authors:  Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2006-03

4.  Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Authors:  Joanna Kitley; Patrick Waters; Mark Woodhall; M Isabel Leite; Andrew Murchison; Jithin George; Wilhelm Küker; Saleel Chandratre; Angela Vincent; Jacqueline Palace
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

5.  Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis.

Authors:  Sean J Pittock; Vanda A Lennon; Nandini Bakshi; Ling Shen; Andrew McKeon; Hong Quach; Farren B S Briggs; Allan L Bernstein; Catherine A Schaefer; Lisa F Barcellos
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

6.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Raul N Mandler; Dorian McGavern; Wolfgang Bruck; Gerald Gleich; Richard M Ransohoff; Corinna Trebst; Brian Weinshenker; Dean Wingerchuk; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2002-07       Impact factor: 13.501

Review 7.  The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Yong Guo; Bogdan F Gh Popescu; Kazuo Fujihara; Yasuto Itoyama; Tatsuro Misu
Journal:  Brain Pathol       Date:  2014-01       Impact factor: 6.508

8.  Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.

Authors:  Patrick Waters; Markus Reindl; Albert Saiz; Kathrin Schanda; Friederike Tuller; Vlastimil Kral; Petra Nytrova; Ondrej Sobek; Helle Hvilsted Nielsen; Torben Barington; Søren T Lillevang; Zsolt Illes; Kristin Rentzsch; Achim Berthele; Tímea Berki; Letizia Granieri; Antonio Bertolotto; Bruno Giometto; Luigi Zuliani; Dörte Hamann; E Daniëlle van Pelt; Rogier Hintzen; Romana Höftberger; Carme Costa; Manuel Comabella; Xavier Montalban; Mar Tintoré; Aksel Siva; Ayse Altintas; Günnur Deniz; Mark Woodhall; Jacqueline Palace; Friedemann Paul; Hans-Peter Hartung; Orhan Aktas; Sven Jarius; Brigitte Wildemann; Christian Vedeler; Anne Ruiz; M Isabel Leite; Peter Trillenberg; Monika Probst; Sandra Saschenbrecker; Angela Vincent; Romain Marignier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-04-25       Impact factor: 10.154

  8 in total
  1 in total

Review 1.  Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.

Authors:  Aigli G Vakrakou; Maria-Evgenia Brinia; Ioanna Svolaki; Theodore Argyrakos; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.